Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company PanGenetics B.V.
DescriptionAntibody that agonizes the CD40 receptor
Molecular Target CD40
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationB cell lymphoma
Indication DetailsTreat B cell lymphoma and other B cell mediated diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today